兔抗TMEM45A多克隆抗體

Background:

High expression and prognostic value of TMEM45A has been recently reported in various types of human tumors. High levels of TMEM45A expression in tumors may be indicative of potential resistance to cancer therapy, making TMEM45A an interesting biomarker for resistance.

Applications:

ELISA, IHC

Name of antibody:

TMEM45A

Immunogen:

Synthetic peptide of human TMEM45A

Full name:

transmembrane protein 45A

Synonyms:

DERP7; DNAPTP4

SwissProt:

Q9NWC5

ELISA Recommended dilution:

5000-10000

IHC positive control:

Human cervical cancer and Human tonsil

IHC Recommend dilution:

25-100